Neuren shares FDA feedback on NNZ-2591 development plans in HIE and PTHS, with next steps and management insights. The post ...

By Ahmed Aboulenein WASHINGTON, Feb 1 (Reuters) - The U.S. Food and Drug Administration on Sunday began accepting requests to ...

Analysis from continued follow-up of Phase 1/2 clinical trial data in Hunter syndrome (MPS II) reinforces potential for tividenofusp alfa (DNL310) to address full disease spectrumLaunch readiness ...

A Democratic lawmaker is raising new concerns about a Food and Drug Administration program designed to drastically shorten ...

As part of its enforcement activities, the Food and Drug Administration (FDA) sends warning letters to entities under its jurisdiction. Some letters are not posted for public view until weeks or ...

For every dollar spent on a lottery ticket, 63 cents goes toward prizes. Nine cents toward lottery sales commissions and 3 ...

Conservation efforts in Liberia are facing what environmental advocates describe as an unprecedented setback under the ...

Conservation efforts in Liberia are facing what environmental advocates describe as an unprecedented setback under the current leadership of the Forestry Development Authority (FDA), following ...

NTLA stock faces binary risk: success could unlock multi-billion dollar markets, while setbacks may erase hundreds of ...

A milestone in the treatment of Duchenne muscular dystrophy (DMD) passed recently with remarkably little public notice. That ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2026 first quarter ended December 31, 2025. The Company is hosting a conference call today, February 5, ...

The Senate failed to pass a massive spending bill on Thursday—which includes the rare pediatric PRV program but also funding ...